ACCURE Therapeutics
Manufacturing · Spain · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Reixac Torres R+d+i Baldiri 4-8, Barcelo...Phone Number
+34 931258607Website
accure.healthRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ACCURE Therapeutics
Accure Therapeutics is a private translational neuroscience R&D company. Based in Barcelona (Spain), it was launched in 2020 with a Series A funding led by Alta Life Sciences Spain I and supported by the Centre for Technological and Industrial Development (CDTI). This European company with an international mindset boasts a unique portfolio of three new chemical entity programs pursuing innovative targets - with potential to accommodate others. Accure aims to develop new disease modifying drugs to treat serious conditions such as optic neuritis, multiple sclerosis, Parkinson's disease and epilepsy. With an experienced business and scientific team, Accure Therapeutics is one of the few companies that operate in an agnostic fashion on initial science to deliver cutting-edge drugs in CNS.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ACCURE Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at ACCURE Therapeutics
Earning: See what the market has to say on ACCURE Therapeutics recently announced quarterly report
Click to see if ACCURE Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ACCURE Therapeutics has new funding data
Check out if ACCURE Therapeutics is spiking on competitors!
ACCURE Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ACCURE Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ACCURE Therapeutics launches new products
Recommended Actions
Find VP level buyers at ACCURE Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
ACCURE Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ACCURE Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ACCURE Therapeutics.
ACCURE Therapeutics financials insights
Gather financial insights about ACCURE Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$1.6M
ACCURE Therapeutics Tech Stack
A closer look at the technologies used by ACCURE Therapeutics
See more technologies
ACCURE Therapeutics News & Media
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Lausanne, Switzerland, and Barcelona, Spain, Mar 2, 2022 - (ACN Newswire) - Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, and Accure Therapeutics, a private translational neuroscience R&D company, today announced a licensing agreement granting Oculis exclusive global rights to develop and commercialize ACT-01, a potentially disease-modifying therapy to protect and prevent damage to the op
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ACCURE Therapeutics
Sign Up For FreeTo access detailed company insights
Accure Therapeutics is a private translational neuroscience R&D company. Based in Barcelona (Spain), it was launched in 2020 with a Series A funding led by Alta Life Sciences Spain I and supported by the Centre for Technological and Industrial Development (CDTI). This European company with an international mindset boasts a unique portfolio of three... Read More
